Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: Stuki who wrote (67468)	9/17/2007 11:31:42 AM
From: Chris Forte	Read Replies (3) \| Respond to of 120415

News from ESFS looks positive. Off the top of your head do you know anything about the company...share count etc? Like many of the companies you discuss here, this one is intriguing.

To: Stuki who wrote (67468)	9/18/2007 3:21:10 PM
From: Chris Forte	Read Replies (3) \| Respond to of 120415

AXK 2.11 x 2.15 AXK is an interesting medical play. They've spent a lot of time and effort developing an accurate, rapid test for bacteria, something that in this day and age of superbug infections and over-prescribed antibiotics is a must. What's really interesting is the POINT they are at in their development. They are getting close to a pay-day (licensce or joint venture deal) for their technology. They've proven the tech works - now they just need a big brother. They are out there shaking a lot of hands right now. Sometimes you invest in one of these LONG shots and you have to wait a LONG time while they prove their tech. AXK has been grinding it out with a slow, steady running attack and they are in the red zone, finally. That's my hunch anyway. That makes it a timely investment, imho. Another nice factor...they only have 10M shares out. It trades thin. Any good news like a license deal or partnership should pop the stock. High risk, high reward.